Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer
2 other identifiers
observational
40
1 country
1
Brief Summary
To find good information about medullary thyroid cancer that is easy to understand and reliable, so researchers aim to design some new educational materials to help.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2025
CompletedStudy Start
First participant enrolled
August 15, 2025
CompletedFirst Posted
Study publicly available on registry
August 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2028
ExpectedApril 2, 2026
March 1, 2026
8 months
June 20, 2025
March 31, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Questionnaires/Survey Measures
Through study completion; an average of 1 year
Interventions
* Questionnaires/Survey Measures * Qualitative Instruments
Eligibility Criteria
MD Anderson Cancer Center
You may qualify if:
- Provision of signed and dated informed consent form
- Males and females; Age: ≥18 years old
- Identified ethnicity as "Hispanic" or "Latino/Latina"
- Ability to read, write, and speak Spanish
- Those who are pregnant are eligible to participate
- Have or will face this decision, including: a. Participant/survivor - who has medullary thyroid carcinoma, as determined by a clinician or documented in Multi-Institutional Medullary Thyroid Cancer Collaborative Registry; b. Caregiver/family member - of Participant/survivor who has medullary thyroid carcinoma, as nominated by the Participant/survivor
You may not qualify if:
- Those \< age 18
- Ethnic identity as non-Hispanic or non-Latino/a individual
- Individuals with cognitive or psychological impairment (e.g., depression, anxiety, severe mental illness as documented in the registry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth Grubbs, MD
eggrubbs@mdanderson.org
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2025
First Posted
August 26, 2025
Study Start
August 15, 2025
Primary Completion
March 31, 2026
Study Completion (Estimated)
March 31, 2028
Last Updated
April 2, 2026
Record last verified: 2026-03